SavedAdd your journal

Journals / Türk Osteoporoz Dergisi / 2021 / Cilt: 27 - Sayı: 3

Musculoskeletal and Peripheral Nervous System Involvement in a Patient UndergoingChronic Hemodialysis: A Case Report and Literature Review

Kronik Hemodiyaliz Hastasında Kas İskelet ve Periferik Sinir Sistemi Tutulumu: Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Zeynep Tuba BAHTİYARCA
Fatma Aytül ÇAKCI
Pages
173–178
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case report presents a patient who is undergoing chronic hemodialysis and is diagnosed with renal osteodystrophy, dialysis amyloidosis, osteoporosis, and uremic neuropathy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Musculoskeletal system manifestations in chronic renal insufficiency are caused by complex bone metabolism alterations, which is now described under the umbrella term of chronic kidney disease mineral- and bone-related disorder instead of renal osteodystrophy, and iatrogenic processes related to renal replacement treatment.
📊
Key Findings & Data:Musculoskeletal and peripheral nervous system involvement is common, especially in patients with end-stage renal failure who undergo hemodialysis for a long time.
💡
Conclusion & Impact:This case report presents a patient who is undergoing chronic hemodialysis and is diagnosed with renal osteodystrophy, dialysis amyloidosis, osteoporosis, and uremic neuropathy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Musculoskeletal system manifestations in chronic renal insufficiency are caused by complex bone metabolism alterations, which is now described under the umbrella term of chronic kidney disease mineral- and bone-related disorder instead of renal osteodystrophy, and iatrogenic processes related to renal replacement treatment. Musculoskeletal and peripheral nervous system involvement is common, especially in patients with end-stage renal failure who undergo hemodialysis for a long time. This case report presents a patient who is undergoing chronic hemodialysis and is diagnosed with renal osteodystrophy, dialysis amyloidosis, osteoporosis, and uremic neuropathy

Özet

Kronik böbrek yetmezliğinde görülen kas iskelet sistemi bulguları, renal osteodistrofi yerine artık kronik böbrek hastalığı-kemik ve mineral bozukluğu şemsiye terimi altında tarif edilen kompleks kemik metabolizması değişikliklerinin yanı sıra renal replasman tedavisine ilişkin iyatrojenik süreçlerden kaynaklanmaktadır. Özellikle uzun süre hemodiyalize giren son dönem böbrek yetmezliği olan hastalarda kas iskelet ve periferik sinir sistemi tutulumu yaygındır. Bu olgu sunumunda renal osteodistrofi, diyaliz amiloidozu, osteoporoz ve üremik nöropati tanısı konulan bir kronik hemodiyaliz hastası sunulmuştur

🔖

Cite This Article

BAHTİYARCA, Z. T., ÇAKCI, F. A. (2022). Musculoskeletal and Peripheral Nervous System Involvement in a Patient UndergoingChronic Hemodialysis: A Case Report and Literature Review. Türk Osteoporoz Dergisi, Cilt: 27 - Sayı: 3, 173–178. https://ajindex.com/articles/639615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013;382:260-72
  2. Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altiparmak MR, et al. A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant 2011;26:1862- 71
  3. Türkiye’de Nefroloji, Diyaliz ve Transplantasyon. TC Sağlık Bakanlığı ve Türk Nefroloji Derneği Ortak Raporu. 2018
  4. Kurer MH, Baillod RA, Madgwick JC. Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years. J Bone Joint Surg Br 1991;73:271-6
  5. Lim CY, Ong KO. Various musculoskeletal manifestations of chronic renal insufficiency. Clin Radiol 2013;68:e397-411
  6. Ramaswamy D, Efthimiou P, Gnanasekharan I, Soni A. Management of musculoskeletal complications in endstage renal disease: an update. Clin Rheumatol 2006;25:440-2
  7. Scarpioni R, Ricardi M, Albertazzi V, De Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis 2016;9:319-28
  8. Eastwood JB, Paizanas M. Renal bone disease. In:Hochberg MC,editors Rheumatology 3rd ed Philadelphia: Elsevier; 2003. p. 2133-8
  9. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney DiseaseMineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-130
  10. Terzibaşoğlu AM, Pekpak M, Akarırmak Ü. Renal Osteodistrofi. Osteoporoz Dünyasından 2004;10:170-6
  11. Delanaye P, Dubois BE, Jouret F, Krzesinski JM, Moranne O, Cavalier E. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? Clin Chim Acta 2013;417:35-8
  12. Murphey MD, Sartoris DJ, Quale JL, Pathria MN, Martin NL. Musculoskeletal manifestations of chronic renal insufficiency. Radiographics 1993;13:357-79
  13. Martin KJ, González EA. Metabolic bone disease in chronic kidney disease. J Am Soc Nephrol 2007;18:875-85
  14. Ureña P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003;18:2325-31
  15. Gupta R, Mohammed AM, Alenizi EK, Ben Nekhi A. Bone mineral density in Kuwaiti patients with end-stage renal disease. Med Princ Pract 2011;20:156-8
  16. Miller